Correlação entre microbiota intestinal e distúrbios neurológicos
DOI:
https://doi.org/10.33233/eb.v22i6.5570Palavras-chave:
Eixo intestino-encéfalo, Influência humoral da microbiota, Distúrbios neurológicosResumo
A microbiota intestinal, composta por uma diversidade de microrganismos, exerce um papel crucial na digestão, absorção de nutrientes e na saúde geral do hospedeiro. Sua composição varia conforme fatores individuais, como dieta, idade, genética e ambiente. Apesar da compreensão da influência dos intestinos delgado e grosso na produção de hormônios como a serotonina, os efeitos de alterações na microbiota no sistema nervoso ainda são pouco elucidados. Este artigo explora as descobertas científicas recentes sobre este eixo intestino-encéfalo enfatizando diversos estudos que investigaram os efeitos da microbiota intestinal no comportamento e no sistema nervoso central.
Referências
Lanxiang Liu, Haiyang Wang, Xueyi Chen, Peng Xie. Gut microbiota: a new insight into neurological diseases. Chin Med J. 2023;136(11):1261-77. doi: 10.1097/CM9.0000000000002212
Murakami T, Kamada K, Mizushima K, Higashimura Y, Katada K, Uchiyama K, et al. Changes in intestinal motility and gut microbiota composition in a rat stress model. Digestion. 2017;95(1):55-60. doi: 10.1159/000452364
Cryan JF, O’Riordan KJ, Cowan CSM, Sandhu KV, Bastiaanssen TFS, Boehme M, et al. The microbiota-gut-brain axis. Physiol Rev. 2019;99(4):1877-2013. doi: 10.1152/physrev.00018.2018
Faulin T, Estadella D. Alzheimer’s disease and its relationship with the microbiota-gut-brain axis. Arq gastroenterol. 2023.;60(1). doi: 10.1590/S0004-2803.202301000-17
Nannan Li, Qi Wang, Yan Wang, Anji Sun, Yiwei Lin, Ye Jin, Xiaobai Li, et al.. Fecal microbiota transplantation from chronic unpredictable mild stress mice donors affects anxiety-like and depression-like behavior in recipient mice via the gut microbiota-inflammation-brain axis. Stress. 2019;22(5):592-602. doi: 10.1080/10253890.2019.1617267
Zheng P, Zeng B, Liu M, Chen J, Pan J, Han Y, et al. The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice. Sci Adv. 2019;5(2):eaau8317. doi: 10.1126/sciadv.aau8317
Mejía-Granados DM, Villasana-Salazar B, Coan AC, Balthazar MLF, Godoi AB, Canto AM, et al. Gut microbiome in neuropsychiatric disorders. Arq Neuro-Psychiatr. 2022;80(2). doi: 10.1590/0004-282X-ANP-2021-0052
Aho VTE, Pereira PAB, Voutilainen S, Paulin L, Pekkonen E, Auvinen P, et al. Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression. EBioMedicine. 2019;44:691-707. doi: 10.1016/j.ebiom.2019.05.064
Glover ME, Cohen JL, Singer JR, Sabbagh MN, Rainville JR, Hyland MT, et al. Examining the role of microbiota in emotional behavior: antibiotic treatment exacerbates anxiety in high anxiety-prone male rats. Neuroscience. 2021;459:179-97. doi: 10.1016/j.neuroscience.2021.01.030
Ping Liu, Li Wu, et al. Altered microbiomes distinguish Alzheimer’s disease from amnestic mild cognitive impairment and health in a Chinese cohort. Brain, Behavior, and Immunity 2019;80:633-43. doi: 10.1016/j.bbi.2019.05.008
Vogt NM, Kerby RL, et al. Gut microbiome alterations in Alzheimer’s disease. Scientific Reports. 2017;7:13537. [acesso em 25 ago 2023]; Disponível em: https://www.nature.com/articles/s41598-017-13601-y
Chunxiao Li, Li Cui et al. Gut microbiota differs between parkinson’s disease patients and healthy controls in Northeast China. Front Mol Neurosci. 2019;12. doi: 10.3389/fnmol.2019.00171
Arora K, Green M, Prakash S. The microbiome and Alzheimer's Disease: potential and limitations of prebiotic, synbiotic, and probiotic formulations. Front Bioeng Biotechnol. 2020;8:537847. doi: 10.3389/fbioe.2020.537847
Naomi R, Embong H, Othman F, Ghazi HF, Maruthey N and Bahari H. Probiotics for Alzheimer's disease: a systematic review. Nutrients. 2021;14(1):20. doi: 10.3390/nu14010020
Cekanaviciut E, Yoo BB, Runia TF, Baranzini SE, et al. Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models. PNAS. 2017;114(40):10713-18. doi: 10.1073/pnas.1711235114
Cantarel BL, Waubant E, et al. Gut microbiota in multiple sclerosis: possible influence of immunomodulators. Journal of Investigating Medicine. 2015 ;63(5):729-34. doi: 10.1097/JIM.0000000000000192
Keshavarzian A, Green SJ, et al. Colonic bacterial composition in Parkinson's disease. Movement Disorders. 2015;10:1351-60. doi: 10.1002/mds.26307
Aho VTE, Houser MC, at al. Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson’s disease. Molecular Neurodegeneration. 2021;16:6. doi: 10.1186/s13024-021-00427-6
Na Li, Xingcui Wang, et al. Change of intestinal microbiota in cerebral ischemic stroke patients. BMC Microbiology. 2019;19:191. doi: 10.1186/s12866-019-1552-1
Kihyun Lee, Namil Kim at al. Gut bacterial dysbiosis in children with intractable epilepsy. J Clin Med. 2021;10(5). doi: 10.3390/jcm10010005
Anjiao Peng, Xiangmiao Qiu, et al. Altered composition of the gut microbiome in patients with drug-resistant epilepsy. Epilepsy Research. 2018;147:102-07. doi: 10.1016/j.eplepsyres.2018.09.013
Publicado
Edição
Seção
Licença
Copyright (c) 2024 Clara de Almeida e Araujo Leite , Juan Pablo Lemos dos Santos , Luciana Armada, Marco Antonio Araujo Leite, Catarine Torquato Barcellos , Marco Orsini
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
